ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $857,438 | -39.6% | 7,997 | -31.2% | 0.01% | -46.7% |
| Q4 2022 | $1,419,517 | -99.9% | 11,623 | -24.0% | 0.02% | -11.8% |
| Q3 2022 | $1,578,949,000 | +110548.1% | 15,291 | -0.4% | 0.02% | +21.4% |
| Q2 2022 | $1,427,000 | -27.7% | 15,349 | -8.8% | 0.01% | -6.7% |
| Q1 2022 | $1,975,000 | -18.3% | 16,825 | -6.3% | 0.02% | +66.7% |
| Q4 2021 | $2,416,000 | – | 17,958 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |